Join
Live feed
·
INSIDERFilingvia Quantisnow
Atara Biotherapeutics Inc. logo

EVP, Chief Regulatory Officer Henrich Jill sold $11,198 worth of shares (1,000 units at $11.20), decreasing direct ownership by 5% to 19,378 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ATRA (Atara Biotherapeutics Inc.) and more on Quantisnow.